Exportin: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 15: | Line 15: | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
===XPO-1=== | |||
[[4bsm]], [[4bsn]] – hXPO – human<br /> | [[4bsm]], [[4bsn]] – hXPO – human<br /> | ||
Line 31: | Line 31: | ||
[[2l1l]] – hXPO residues 504-630 + cAMP-dependent protein kinase inhibitor α - NMR<br /> | [[2l1l]] – hXPO residues 504-630 + cAMP-dependent protein kinase inhibitor α - NMR<br /> | ||
===XPO-t=== | |||
[[3ibv]] – fyXPO – fission yeast<br /> | [[3ibv]] – fyXPO – fission yeast<br /> | ||
[[3icq]] – fyXPO + GTP-binding nuclear protein + RNA <br /> | [[3icq]] – fyXPO + GTP-binding nuclear protein + RNA <br /> | ||
===XPO-5=== | |||
[[3a6p]] – hXPO + peptide + pre-microRNA <br /> | [[3a6p]] – hXPO + peptide + pre-microRNA <br /> |